Published
Anti-Ulcer Tablet of Pantoprazole: A Brief Review Of Its Pharmacological Properties and Therapeutic Uses with Respect To Effervescent Tablets
Published in April 2023 Issue 2 (Vol. 13, Issue 2, 2023)

Abstract
Peptic ulcer is a common gastrointestinal disease seen among many peoples. It may be caused by irregular food habits, spicy foods, either an infection or long-time use of medications, drugs and stress. An ulcer depends upon the presence of acid and peptic activity in gastric juice plus a breakdown in mucosal defences. A number of anti-ulcer drug are available for curing ulcer disease. Standard treatment is including antibiotics and proton pump inhibitors. But the same time these drugs are expensive and there are many side effects caused by these drugs comparing to other herbal medicines. Pantoprazole is an irreversible proton pump inhibitor (PPI) that reduces gastric acid secretion. It is used to treat stomach ulcers, gastro-oesophageal reflux disease (GORD), acid reflux, and heartburn. Zollinger-Ellison syndrome is a rare disorder brought on by a pancreatic or intestinal tumour that is treated with pantoprazole. Both a generic and a brand-name version of the oral tablet medication pantoprazole are offered. A stomach H+/K+-ATPase (hydrogen-potassium adenosine triphosphatase) inhibitor is pantoprazole. Although oral dose forms are the most common drug, they nevertheless have significant drawbacks compared to other delivery systems, such as the possibility of medication absorption that is too sluggish and complicated by gastric residence time. It can be treated by using a lesser dosage of the medication instead of taking it in liquid form. Another technique is the effervescent technique, which can be used to create a dosage form that can speed up the time the drug dissolves and combines with the body. This technique is typically employed with preparations for rapid release. Effervescent tablets are being used more frequently and widely to modify the behaviour of drug release, such as in sustained and controlled release preparations, pulsatilla drug delivery systems, and so forth, along with the development of novel pharmaceutical techniques. The present review illustrated about the etiology of peptic ulcer, its complications, pharmacological property of pantoprazole antiulcer drug and the new effervescent tablet methodology.
Authors (4)
Dhivakaran A¹
View all publications →Gomathi M
View all publications →Shamini S
View all publications →Priyanga G
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
April 2023 Issue 2 (Vol. 13, Issue 2, 2023)- Article ID:
- AJPTR132003
- Paper ID:
- AJPTR-01-000393
- Published Date:
- 2023-04-01
Article Impact
Views:2,860
Downloads:2,372
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
A¹ & M & S & G (2023). Anti-Ulcer Tablet of Pantoprazole: A Brief Review Of Its Pharmacological Properties and Therapeutic Uses with Respect To Effervescent Tablets. American Journal of PharmTech Research, 13(2), xx-xx. DOI:https://doi.org/10.5281/zenodo.7878369
Article Actions
More from this Issue
Quality Assurance Of Drug Information Services Provided In A Tertiary Care Hospital In Calicut
Arun Krishna A, Sahla, As...Read more →

